CSIMarket
 


P3 Health Partners Inc   (PIII)
Other Ticker:  
 
 

PIII's Revenue Growth by Quarter and Year

P3 Health Partners Inc 's Revenue results by quarter and year




PIII Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 346.86 258.21 491.06
III Quarter September - 288.35 248.26 0.00
II Quarter June - 329.09 269.45 0.00
I Quarter March 388.49 302.08 273.54 0.00
FY   388.49 1,266.38 1,049.46 491.06



PIII Revenue first quarter 2024 Y/Y Growth Comment
P3 Health Partners Inc achieved in the first quarter 2024, above Company average Revenue growth of 28.6% year on year, to $ 388.49 millions.

Looking into first quarter 2024 results within Medical Equipment & Supplies industry 53 other companies have achieved higher Revenue growth. While P3 Health Partners Inc ' s Revenue rise of 28.6% ranks overall at the positon no. 876 in the first quarter 2024.




PIII Revenue ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - 34.33 % -47.42 % -
III Quarter September - 16.15 % - -
II Quarter June - 22.13 % - -
I Quarter March 28.6 % 10.43 % - -
FY   - 20.67 % 113.71 % -

Financial Statements
P3 Health Partners Inc 's first quarter 2024 Revenue $ 388.49 millions PIII's Income Statement
P3 Health Partners Inc 's first quarter 2023 Revenue $ 302.08 millions Quarterly PIII's Income Statement
New: More PIII's historic Revenue Growth >>


PIII Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - 20.29 % 4.01 % -
III Quarter September - -12.38 % -7.86 % -
II Quarter June - 8.94 % -1.5 % -
I Quarter March 12 % 16.99 % -44.3 % -
FY (Year on Year)   - 20.67 % 113.71 % -




Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #54
Healthcare Sector #139
Overall #876

Revenue Y/Y Growth Statistics
High Average Low
40.99 % 17.8 % -8.16 %
(Mar 31 2023)   (Sep 30 2023)
Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #54
Healthcare Sector #139
Overall #876
Revenue Y/Y Growth Statistics
High Average Low
40.99 % 17.8 % -8.16 %
(Mar 31 2023)   (Sep 30 2023)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

P3 Health Partners Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
5456261022.22 % 496023725.31 % -44.3 %
(Dec 31 2021)  


PIII's I. Quarter Q/Q Revenue Comment
P3 Health Partners Inc achieved in the I. Quarter 2024 below company average Revenue rise of 12% quarter on quarter, to $ 388.49 millions.

Within Medical Equipment & Supplies industry 7 other companies have achieved higher Revenue quarter on quarter growth. While P3 Health Partners Inc 's Revenue growth quarter on quarter, overall rank is 222.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #29
Overall #222
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #29
Overall #222
Revenue Q/Q Growth Statistics
High Average Low
5456261022.22 % 496023725.31 % -44.3 %
(Dec 31 2021)  


PIII's I. Quarter Q/Q Revenue Comment
P3 Health Partners Inc achieved in the I. Quarter 2024 below company average Revenue rise of 12% quarter on quarter, to $ 388.49 millions.

Within Medical Equipment & Supplies industry 7 other companies have achieved higher Revenue quarter on quarter growth. While P3 Health Partners Inc 's Revenue growth quarter on quarter, overall rank is 222.


P3 Health Partners Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
Cumulative Revenue 12 Months Ending $ 1,352.79 $ 1,266.38 $ 1,177.73 $ 1,137.64 $ 1,078.00
Y / Y Revenue Growth (TTM) 25.49 % 20.67 % -8.16 % 10.02 % 40.99 %
Year on Year Revenue Growth Overall Ranking # 230 # 253 # 263 # 513 # 315
Seqeuential Revenue Change (TTM) 6.82 % 7.53 % 3.52 % 5.53 % 2.72 %
Seq. Revenue Growth (TTM) Overall Ranking # 1392 # 2478 # 716 # 827 # 641




Cumulative Revenue growth Comment
P3 Health Partners Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 25.49% year on year, to $ 1,353 millions if the fiscal year would have ended in Mar 31 2024.
P3 Health Partners Inc 's trailing twelve months Revenue growth was higher than company's average 17.8% and higher than 20.67% growth in Dec 31 2023.
But sequential increase was beneth at 6.82 % from $1266.38 millions recorded in twelve months ending a quarter before.
We witness slowdown happening, more obvious as we look at average sequential historic advancement what is higher at 17.8% Jessica M. Evans noted.
The growth was even higher from the previous reporting period clinched at 6.82 % increase from $1266.38 millions in twelve months ending a quarter before.

In the Healthcare sector 67 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 230, from total ranking in previous quarter at 253.

Revenue TTM Q/Q Growth Statistics
High Average Low
40.99 %
17.8 %
-8.16 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 81
Healthcare Sector # 68
Overall # 230

Revenue TTM Y/Y Growth Statistics
High Average Low
40.99 %
17.8 %
-8.16 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 81
Sector # 231
S&P 500 # 1392
Cumulative Revenue growth Comment
P3 Health Partners Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 25.49% year on year, to $ 1,353 millions if the fiscal year would have ended in Mar 31 2024.
P3 Health Partners Inc 's trailing twelve months Revenue growth was higher than company's average 17.8% and higher than 20.67% growth in Dec 31 2023.
But from the previous reporting period rise was less at 6.82 % from $1266.38 millions recorded in twelve months ending a quarter Dec 31 2023 Jessica M. Evans went on.
It appears to be drop-off in progress, more noticeable as we look at typical Q/Q TTM Revenue rise that is better at17.8% Jessica M. Evans wrote.
The growth is even more impressive from twelve months ended Dec 31 2023 exhibited at 6.82 % increase from $1266.38 millions in twelve months ending a quarter before.

In the Healthcare sector 67 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 230, from total ranking in previous quarter at 253.

Revenue TTM Q/Q Growth Statistics
High Average Low
40.99 %
17.8 %
-8.16 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 81
Healthcare Sector # 68
Overall # 230

Revenue TTM Y/Y Growth Statistics
High Average Low
40.99 %
17.8 %
-8.16 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 81
Sector # 231
S&P 500 # 1392




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PIII's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for PIII's Competitors
Revenue Growth for P3 Health Partners Inc 's Suppliers
Revenue Growth for PIII's Customers

You may also want to know
PIII's Annual Growth Rates PIII's Profitability Ratios PIII's Asset Turnover Ratio PIII's Dividend Growth
PIII's Roe PIII's Valuation Ratios PIII's Financial Strength Ratios PIII's Dividend Payout Ratio
PIII's Roa PIII's Inventory Turnover Ratio PIII's Growth Rates PIII's Dividend Comparisons



Companies with similar Revenue rise for the quarter ending Mar 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2024
Prosomnus Inc 47.63%$ 47.632 millions
Aurinia Pharmaceuticals Inc 46.19%$ 46.191 millions
Agios Pharmaceuticals Inc 46.00%$ 45.998 millions
Hims and Hers Health Inc 45.78%$ 45.775 millions
Enzon Pharmaceuticals inc 44.74%$ 44.743 millions
Genedx Holdings Corp 44.67%$ 44.674 millions
Astrotech Corp42.86%$ 42.857 millions
Adma Biologics Inc 42.51%$ 42.511 millions
Evolus Inc 42.21%$ 42.214 millions
Agilon Health Inc 41.21%$ 41.210 millions
Clearpoint Neuro Inc 40.60%$ 40.604 millions
Orthopediatrics Corp39.84%$ 39.844 millions
Theravance Biopharma inc 39.22%$ 39.224 millions
Corcept Therapeutics Inc38.95%$ 38.952 millions
Zai Lab Limited38.78%$ 38.779 millions
Qhslab Inc 38.49%$ 38.489 millions
Tela Bio Inc 38.28%$ 38.277 millions
Shockwave Medical Inc 35.72%$ 35.720 millions
Biocryst Pharmaceuticals Inc 34.87%$ 34.870 millions
Deciphera Pharmaceuticals Inc 34.55%$ 34.546 millions
United Therapeutics Corporation33.70%$ 33.695 millions
Cyclo Therapeutics Inc 32.83%$ 32.832 millions
Lifemd Inc 32.31%$ 32.307 millions
Maxcyte inc 32.25%$ 32.248 millions
Eton Pharmaceuticals Inc 32.11%$ 32.108 millions
Agile Therapeutics Inc32.07%$ 32.074 millions
Guardant Health Inc 30.90%$ 30.903 millions
Harrow Inc 30.38%$ 30.383 millions
Harmony Biosciences Holdings inc 29.38%$ 29.385 millions
Axonics Inc 29.16%$ 29.162 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com